My compounded semaglutide provider shut down. Where should I move my treatment?

Sorry that happened — that’s stressful. Here’s a practical, safe plan for where to move your semaglutide treatment and which providers/products to consider.

Key principle

• Prefer an FDA‑approved product prescribed by a licensed clinician rather than continuing compounded semaglutide. FDA‑approved drugs have consistent dosing, clear labeling, and manufacturer support programs. Compounded products can vary in strength and sterility.

Which FDA‑approved medicines to ask about

• Wegovy (semaglutide, Novo Nordisk) — FDA‑approved for chronic weight management (higher-dose semaglutide).
• Ozempic (semaglutide, Novo Nordisk) — approved for type 2 diabetes; frequently used under clinician guidance for weight effects.
• Rybelsus (oral semaglutide, Novo Nordisk) — an oral option for type 2 diabetes.
• Mounjaro (tirzepatide, Eli Lilly) — approved for type 2 diabetes and often discussed for weight loss.
• Zepbound (tirzepatide, Eli Lilly) — approved for chronic weight management (if weight loss is your goal).

Where to get a prescription / who to see

• Your primary care provider (PCP). They can usually manage the switch, write the prescription, and coordinate dosing.
• An endocrinologist (if you have diabetes or complex metabolic needs).
• A board‑certified obesity medicine specialist (ABOM) for weight management. You can find ABOM doctors via the ABOM website.
• Telemedicine clinics that specialize in metabolic/weight-care and can prescribe GLP‑1/GIP drugs:
  • Calibrate — focuses on metabolic health and GLP‑1–based programs.
  • One Medical — primary‑care oriented and able to manage chronic meds with virtual/in‑person visits.
  • PlushCare — telehealth primary care visits and can prescribe medications.
  • Hims/Hers — offers telehealth prescribing for weight management in some areas. (Availability varies by state and platform; check whether they treat your condition and can prescribe your preferred medication.)

Practical steps to take now

1. Get your medical record: obtain last prescription, dose, and dates from the compounding provider (or your chart) to show the new prescriber.
2. Book an appointment with your PCP/endocrinologist/telemedicine clinic and say you need to transition from compounded semaglutide to an FDA‑approved product.
3. Discuss which FDA product fits your indication (diabetes vs weight loss), dose equivalence, and any need to restart or re‑titrate dosing.
4. Ask about insurance prior authorization — many insurers require it for Wegovy, Ozempic, Mounjaro, etc. Prescription may need to go to a specialty pharmacy (Accredo, CVS Caremark specialty, Optum, Diplomat).
5. Check manufacturer support and savings programs: Novo Nordisk (Wegovy/Ozempic/Rybelsus) and Eli Lilly (Mounjaro/Zepbound) have patient support sites and savings/co-pay programs for eligible patients.
6. Avoid ordering semaglutide again from an unknown compounding pharmacy without verifying licensure and quality; prefer FDA‑approved products unless a clinician documents a specific reason for compounding.

If you want, I can:

• Help draft a message to send to a new prescriber summarizing your history and last dose.
• Search for nearby endocrinologists or ABOM specialists if you tell me your city/state.
• Check manufacturer support pages or likely prior‑authorization steps if you tell me which drug (Wegovy/Ozempic/Rybelsus/Mounjaro/Zepbound) you’d prefer and whether you have insurance.

Which of those would you like help with, and is your treatment for diabetes or weight management?